Ichiro Abe. Efficacy and Safety of Low-Dose Ipragliflozin, a Selective Sodium Glucose Transporter 2 Inhibitor, in Patients with Type 2 Diabetes Mellitus. Int. J. of Allied Med. Sci. and Clin. Res. [Internet]. 2020 Aug. 6 [cited 2026 Apr. 16];4(3):376-82. Available from: https://ijamscr.com/ijamscr/article/view/283